Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitors
Hua-Poo Su, Keith Rickert, Christine Burlein, et al.
Nature Communications
|
December 19, 2019
Discovery of a chemical probe for PRDM9
Abdellah Allali-Hassani, Magdalena M Szewczyk, Danton Ivanochko, et al.
Journal of Medicinal Chemistry
|
September 24, 2015
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors
Izzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Journal of Medicinal Chemistry
|
March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
Jack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitors
Hua-Poo Su, Keith Rickert, Christine Burlein, et al.
Nature Communications
|
December 19, 2019
Discovery of a chemical probe for PRDM9
Abdellah Allali-Hassani, Magdalena M Szewczyk, Danton Ivanochko, et al.
Journal of Medicinal Chemistry
|
September 24, 2015
Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors
Izzat T Raheem, Abbas M Walji, Daniel Klein, et al.
Journal of Medicinal Chemistry
|
March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
Jack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Page
of 6